OPPENHEIMER & CO INC

Position in VKTX — Viking Therapeutics, Inc.

CIK 822581 NEW YORK, NY

Position in VKTX

as of Mar 31, 2026 · filed Apr 24, 2026 Compact

Position Value

$4,885,327

-$625,725 QoQ

Shares Held

150,133

-4.2% QoQ

Ownership

0.129%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

OPPENHEIMER & CO INC holds $44,352,224 across 44 Biotechnology names. VKTX ranks #2 (11.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	22,477	$17,366,629
2	VKTX	Viking Therapeutics, Inc. This page	150,133	$4,885,327
3	TYRA	Tyra Biosciences, Inc.	84,192	$3,224,553
4	CAPR	Capricor Therapeutics, Inc.	63,666	$1,935,446
5	VRTX	Vertex Pharmaceuticals Inc / Ma	4,308	$1,923,694
6	CPRX	Catalyst Pharmaceuticals, Inc.	68,116	$1,686,552
7	NTLA	Intellia Therapeutics, Inc.	106,924	$1,370,765
8	TRVI	Trevi Therapeutics, Inc.	100,027	$1,193,322

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,885,327	150,133	-4.2%	Shares	Sole	2026-04-24
2025-12-31	$5,511,052	156,653	-15.0%	Shares	Sole	2026-02-02
2025-09-30	$4,843,771	184,314	+16.5%	Shares	Sole	2025-11-06
2025-06-30	$4,193,042	158,228	+9.5%	Shares	Sole	2025-07-31
2025-03-31	$3,490,713	144,543	+19.4%	Shares	Sole	2025-04-23
2024-12-31	$4,871,534	121,062	+18.3%	Shares	Sole	2025-02-05
2024-09-30	$6,478,132	102,324	+43.5%	Shares	Sole	2024-11-05
2024-06-30	$3,780,302	71,313	+45.7%	Shares	Sole	2024-08-08
2024-03-31	$4,013,408	48,944	+58.6%	Shares	Sole	2024-05-07
2023-12-31	$574,248	30,857	+83.5%	Shares	Sole	2024-02-13
2023-09-30	$186,186	16,819	+31.9%	Shares	Sole	2023-11-08
2023-06-30	$206,693	12,751	—	Shares	Sole	2023-08-03
No filing history on record for this holder in this stock.